Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Jason Aldred; Eric Freire-Alvarez; Alexander V. Amelin; Angelo Antonini; Bruno Bergmans; Filip Bergquist; Manon Bouchard; Kumar Budur; Camille Carroll; K. Ray Chaudhuri; Susan R. Criswell; Erik H. Danielsen; Florin Gandor; Jia Jia; Thomas E. Kimber; Hideki Mochizuki; Weining Z. Robieson; Amy M. Spiegel; David G. Standaert; Saritha Talapala; Maurizio F. Facheris; Victor S.C. Fung

doi:10.1007/s40120-023-00554-w

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Jason Aldred^*
, Eric Freire-Alvarez
, Alexander V. Amelin
, Angelo Antonini
, Bruno Bergmans
, Filip Bergquist
, Manon Bouchard
, Kumar Budur
, Camille Carroll
, K. Ray Chaudhuri
, Susan R. Criswell
, Erik H. Danielsen
, Florin Gandor
, Jia Jia
, Thomas E. Kimber
, Hideki Mochizuki
, Weining Z. Robieson
, Amy M. Spiegel
, David G. Standaert
, Saritha Talapala

Maurizio F. Facheris, Victor S.C. Fung

^*Corresponding author for this work

Peninsula Medical School

Research output: Other contribution › peer-review

25 Downloads (Pure)

Original language	English
DOIs	https://doi.org/10.1007/s40120-023-00554-w
Publication status	Published - 10 Oct 2023

Access to Document

10.1007/s40120-023-00554-w

Correction Continuous Subcutaneous FoslevodopaFoscarbidopa in Parkinsons Disease Safety and Efficacy Results From a 12-Month

Cite this

Aldred, J., Freire-Alvarez, E., Amelin, A. V., Antonini, A., Bergmans, B., Bergquist, F., Bouchard, M., Budur, K., Carroll, C., Chaudhuri, K. R., Criswell, S. R., Danielsen, E. H., Gandor, F., Jia, J., Kimber, T. E., Mochizuki, H., Robieson, W. Z., Spiegel, A. M., Standaert, D. G., ... Fung, V. S. C. (2023, Oct 10). Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. https://doi.org/10.1007/s40120-023-00554-w

@misc{b77ac91884e84e1c8d9ada31bc1a8c1f,

title = "Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson{\textquoteright}s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study",

author = "Jason Aldred and Eric Freire-Alvarez and Amelin, \{Alexander V.\} and Angelo Antonini and Bruno Bergmans and Filip Bergquist and Manon Bouchard and Kumar Budur and Camille Carroll and Chaudhuri, \{K. Ray\} and Criswell, \{Susan R.\} and Danielsen, \{Erik H.\} and Florin Gandor and Jia Jia and Kimber, \{Thomas E.\} and Hideki Mochizuki and Robieson, \{Weining Z.\} and Spiegel, \{Amy M.\} and Standaert, \{David G.\} and Saritha Talapala and Facheris, \{Maurizio F.\} and Fung, \{Victor S.C.\}",

year = "2023",

month = oct,

day = "10",

doi = "10.1007/s40120-023-00554-w",

language = "English",

type = "Other",

}

Aldred, J, Freire-Alvarez, E, Amelin, AV, Antonini, A, Bergmans, B, Bergquist, F, Bouchard, M, Budur, K, Carroll, C, Chaudhuri, KR, Criswell, SR, Danielsen, EH, Gandor, F, Jia, J, Kimber, TE, Mochizuki, H, Robieson, WZ, Spiegel, AM, Standaert, DG, Talapala, S, Facheris, MF & Fung, VSC 2023, Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. https://doi.org/10.1007/s40120-023-00554-w

TY - GEN

T1 - Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

AU - Aldred, Jason

AU - Freire-Alvarez, Eric

AU - Amelin, Alexander V.

AU - Antonini, Angelo

AU - Bergmans, Bruno

AU - Bergquist, Filip

AU - Bouchard, Manon

AU - Budur, Kumar

AU - Carroll, Camille

AU - Chaudhuri, K. Ray

AU - Criswell, Susan R.

AU - Danielsen, Erik H.

AU - Gandor, Florin

AU - Jia, Jia

AU - Kimber, Thomas E.

AU - Mochizuki, Hideki

AU - Robieson, Weining Z.

AU - Spiegel, Amy M.

AU - Standaert, David G.

AU - Talapala, Saritha

AU - Facheris, Maurizio F.

AU - Fung, Victor S.C.

PY - 2023/10/10

Y1 - 2023/10/10

UR - https://pearl.plymouth.ac.uk/pms-research/399/

U2 - 10.1007/s40120-023-00554-w

DO - 10.1007/s40120-023-00554-w

M3 - Other contribution

ER -

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Access to Document

Other files and links

Cite this